This brand name is authorized in Brazil
The drug MYRAFER contains one active pharmaceutical ingredient (API):
1
Iron polymaltose
UNII UM5219H89V - IRON POLYMALTOSE
|
Iron sucrose is composed of a polynuclear iron(III)-hydroxide core surrounded by a large number of non-covalently bound sucrose molecules. The polynuclear iron core has a structure similar to that of the core of the physiological iron storage protein ferritin. The complex is designed to provide, in a controlled manner, utilisable iron for the iron transport and storage proteins in the body (i.e., transferrin and ferritin, respectively). |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Cรขmara de Regulaรงรฃo do Mercado de Medicamentos | Identifier(s): 502416070023004, 502418120024704, 575219120003617, 575219120003717, 575219120003817, 575219120003917, 575219120004017 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.